SCHEMBL6061571

SCHEMBL6061571

CCC(CCC(C)C(=O)O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
APAF1 O14727 1/20 0.50
SRC P12931 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 5/20 0.44
HSD17B10 Q99714 1/20 0.44
CYP2D6 P10635 1/20 0.42
GABBR2 O75899 1/20 0.42
GABBR1 Q9UBS5 1/20 0.42
CCR5 P51681 1/20 0.41
POLB P06746 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP1A2 P05177 1/20 0.41
GABRR1 P24046 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12191565 0.85 APAF1 (0.50) APAF1SRCMEN1KMT2ALMNA
SCHEMBL26549945 0.81 APAF1 (0.41) APAF1MEN1KMT2ALMNAHSD17B10
SCHEMBL25936284 0.81 APAF1 (0.41) APAF1MEN1KMT2ALMNAHSD17B10
SCHEMBL16353333 0.80 TSHR (0.57) APAF1MEN1KMT2ALMNAPOLB
SCHEMBL26478483 0.80 CHRM2 (0.46) LMNAPOLBMAPK1
SCHEMBL4993935 0.80 GABBR2 (0.49) SRCLMNACYP2D6GABBR2GABBR1
SCHEMBL3056333 0.79 GABBR2 (0.47) SRCMEN1KMT2ALMNAHSD17B10
SCHEMBL12228632 0.79 APAF1 (0.55) APAF1SRCLMNACYP2D6GABBR2
SCHEMBL15336464 0.78 ALDH1A1 (0.40) SRCMEN1KMT2ALMNACYP2D6
Hydrogen Peroxide SCHEMBL11212534 0.78 LMNA (0.52) SRCLMNAGABBR2GABBR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9926450-B2 Compound having azo skeleton structure, pigment-dispersing agent, pigment composition, pigment dispersion, and toner CANON KABUSHIKI KAISHA (JP) 2018-03-27 US disclosed
US-9880482-B2 Ultraviolet-curable liquid developer and method of producing same CANON KABUSHIKI KAISHA (JP) 2018-01-30 US disclosed
US-9618867-B2 Pigment dispersion and toner CANON KABUSHIKI KAISHA (JP) 2017-04-11 US disclosed
US-9593243-B2 Compound, pigment dispersing agent, pigment composition, pigment dispersion and toner containing said compound CANON KABUSHIKI KAISHA (JP) 2017-03-14 US disclosed
US-20160349656-A1 ULTRAVIOLET-CURABLE LIQUID DEVELOPER AND METHOD OF PRODUCING SAME CANON KABUSHIKI KAISHA (JP) 2016-12-01 US disclosed
US-20160280925-A1 COMPOUND HAVING AZO SKELETON STRUCTURE, PIGMENT-DISPERSING AGENT, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER CANON KABUSHIKI KAISHA (JP) 2016-09-29 US disclosed
US-20160246200-A1 PIGMENT DISPERSION AND TONER CANON KABUSHIKI KAISHA (JP) 2016-08-25 US disclosed
US-20160208106-A1 COMPOUND HAVING AZO SKELETON, PIGMENT DISPERSANT, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER CANON KABUSHIKI KAISHA (JP) 2016-07-21 US disclosed
US-20160185971-A1 NOVEL COMPOUND, PIGMENT DISPERSING AGENT, PIGMENT COMPOSITION, PIGMENT DISPERSION AND TONER CONTAINING SAID COMPOUND CANON KABUSHIKI KAISHA (JP) 2016-06-30 US disclosed
EP-3021879-A2 METHODS, SYSTEMS, AND COMPOSITIONS FOR PROMOTING BONE GROWTH Cayman Chemical Company, Incorporated (US) 2016-05-25 EP disclosed
WO-2015009991-A2 METHODS, SYSTEMS, AND COMPOSITIONS FOR PROMOTING BONE GROWTH CAYMAN CHEMICAL COMPANY, INC. (US) 2015-01-22 WO disclosed
US-20150004538-A1 AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION AND TONER CANON KABUSHIKI KAISHA (JP) 2015-01-01 US disclosed
US-20150004539-A1 MAGENTA TONER CONTAINING COMPOUND HAVING AZO SKELETON CANON KABUSHIKI KAISHA (JP) 2015-01-01 US disclosed
US-20140377697-A1 CYAN TONER CONTAINING COMPOUND HAVING AZO SKELETON CANON KABUSHIKI KAISHA (JP) 2014-12-25 US disclosed
WO-2014144610-A1 LACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASES AND CONDITIONS CAYMAN CHEMICAL COMPANY, INC. (US) 2014-09-18 WO disclosed
WO-2014144500-A2 METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG CAYMAN CHEMICAL COMPANY, INC. (US) 2014-09-18 WO disclosed
WO-2014015246-A1 DIFLUOROLACTAM COMPOSITIONS FOR EP4-MEDIATED OSTEO RELATED DISEASES AND CONDITIONS CAYMAN CHEMICAL COMPANY, INC. (US) 2014-01-23 WO disclosed
WO-2014015247-A1 DIFLUOROLACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASE AND CONDITIONS CAYMAN CHEMICAL COMPANY, INC. (US) 2014-01-23 WO disclosed
EP-1667957-A2 AMINO ACIDS WITH AFFINITY FOR THE ALPHA2DELTA-PROTEIN Warner-Lambert Company LLC (US) 2006-06-14 EP disclosed
WO-2005030700-A2 AMINO ACIDS WITH AFFINITY FOR THE ALPHA2DELTA-PROTEIN WARNER-LAMBERT COMPANY LLC (US) 2005-04-07 WO disclosed